• Crystal Equity Research maintains $5.25 price target for Moxian
• 75% upside from current price
• Price appreciation could be even higher depending on paid user conversions

Crystal Equity Research published a research report on Moxian, Inc. (NASDAQ: MOXC) in January 2017 and identified a price target of $5.25 for the company. The price target remained unchanged at $5.25 in the August 15 updated report from Crystal Equity, and the report categorized an investment in Moxian as a speculative buy (http://dtn.fm/AmU79). Currently trading near $3.00 per share, reaching the research projection would equate to a 75 percent upside ride for Moxian. That’s the kind of speculative return sought by most investors.

The Crystal Equity Research report highlighted areas of Moxian’s business that could be catalysts for even greater price appreciation. The report cites the company’s memorandum of understanding with Shewn International Group in Shanghai aimed at a joint venture featuring Shewn’s fine wine clubs and using Moxian+ online-to-offline technology. This proposed joint venture with Shewn is an example of a change in market penetration tactics by Moxian, emphasizing pacts with enterprises needing Moxian+ platform payments or any of the unique CRM features created by Moxian. Moxian would earn fees based on a percentage of digital payments traffic by Shewn customers on the Moxian+ platform.

Moxian, Inc. caters to and focuses on the new Chinese consumer and, importantly, bridges e-commerce to brick-and-mortar retail. Moxian provides small- and medium-sized brick-and-mortar businesses with cutting-edge turnkey solutions to attract and maintain customers. Free to the consumer, Moxian’s creative and socially interactive online platforms and mobile applications are moving the burgeoning Chinese consumer from online views to retail purchases at Moxian’s brick-and-mortar retail client locations. Moxian’s seductive social network integrates social media and business into a single platform that offers products, features and services that appeal to consumers, keeping them engaged and referring new customers.

The company’s ingenious online platforms and mobile applications, the Moxian+ User app and the Moxian+ Business app, allow businesses to interface with both new and existing customers. These online interactions provide each business the data to analyze consumer likes, dislikes and trends, providing Moxian’s business customers with invaluable consumer information and a real-time, state-of –the-art CRM. Moxian is in the midst of converting its unpaid platforms to paid, reflected in its joint venture with upscale wine distributor Shewn. This conversion could significantly enhance Crystal Equity’s price target.

One line on the home page of Crystal Equity Research’s website says, “INSIGHT FOR ALPHA RETURNS”. Crystal has set and maintained a target of $5.25 on shares of Moxian, representing a 75 percent upside from the current price. If the conversion to paid users goes as planned, alpha returns could be in the bank.

For more information, visit the company’s website at www.Moxian.com

• Collaborative venture could lead to strengthening of company’s patent portfolio, new commercial opportunities
• Firm receives patent in Australia, anticipates entering that market through cannabinoid licensing arrangements and product distribution partnerships
• LXRP names Allan Spissinger acting chief financial officer

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has begun laboratory work with the National Research Council (“NRC”) (http://dtn.fm/e4oZB). The collaboration will begin studies using LXRP’s patented technologies. The research will include the company’s technology in vitamins, NSAIDs, nicotine and cannabinoids utilizing lipophilic active agents. LXRP has patented technology involving how those agents are ingested into the human body in various edibles, such as beverages, foods, capsules and others means.

LXRP has also named Allan Spissinger (http://dtn.fm/ziT65) as its acting chief financial officer, secretary and treasurer. He has been with the company since September 2014, when he joined as corporate controller. A CPA, he has more than 10 years’ experience in corporate IT infrastructure and software development before focusing of finance and accounting.

The firm, based in Kelowna, British Columbia, Canada, is a food biosciences company which is a technology disrupter for edible CBDs. It markets a high absorption hemp oil formulation for exotic teas, protein energy bars and high absorption hemp oil capsules that aid in the body’s absorption of CBDs. It is focusing on developing more products for the edible cannabis market.

The joint research venture with the NRC will use advanced analytical techniques. Practical application of the resulting research could broaden or strengthen LXRP’s intellectual property portfolio and even lead to additional commercial arrangements, per a recent statement from the company.

LXRP has a number of international patents, including the recent 20-year effective patent approval issued by Australia (http://dtn.fm/D3NMa) for the company’s edible cannabis absorption method, time of onset and taste of cannabinoid’s active agents in food.

“We are very pleased to have received this patent which effectively covers all cannabis oil extract formulated edibles using our technology in Australia,” Chris Bunka, chief executive officer of LXRP, stated in a news release. “This patent award allows us to confidently enter the recently legalized Australian cannabis marketplace where we will seek additional licensing and product distribution partnering opportunities.”

A similar patent was granted in the U.S. in 2016, and Bunka added that LXRP anticipates progress on its patent portfolios throughout the remainder of 2017 and into 2018. In the U.S., the company successfully filed a provisional patent application (http://dtn.fm/0kNSJ) and stock and option awards in June 2017. It expands the company’s existing patent in the U.S. to microwave processing.

For more information, visit the company’s website at www.LexariaEnergy.com

Let us hear your thoughts: Lexaria Bioscience Corp. Message Board

• Incubator of digital app development
• Positioned to benefit from rising ecommerce activity
• Strategy based on the nexus of app development and increasing mobile commerce

A recent report by app market data outfit App Annie sheds some light on the current strategy of technology development company AppSwarm, Inc. (OTC: SWRM). Worth $1.3 trillion in 2016, the app economy is expected to reach $6.3 trillion by 2021, growing a staggering 380 percent over the next five years. According to the report, a review of which appeared in Fortune (http://dtn.fm/v0U7A), mobile commerce, which involves the purchase of goods using a smartphone app, will represent the “single largest driver of the growth of the mobile and app economy.” With these exciting developments set to increase ecommerce activity, AppSwarm plans to gain a competitive edge on two fronts. The innovative incubation accelerator is collaborating with app developers through joint ventures, royalty agreements, marketing partnerships, and outright purchase agreements. It is also acquiring ecommerce sites and currently has four under its wing. Using a proprietary screening process called ‘The Swarm’, AppSwarm continues to execute its strategy of synergistic acquisitions within the software development and related services industry.

Although its public acceptance continues to rise, ecommerce in the U.S. comprises less than 10 percent of retail sales, much less than in China and the Asia-Pacific region. According to App Annie, “Compared to U.S. consumers, Chinese consumers are nearly three times as likely to buy food and groceries via their devices, twice as likely to transfer money using apps, and four times more likely to spend a majority of disposable income on mobile.” As a result, AppSwarm sees an opportunity to apply its current business model to this burgeoning sector.

AppSwarm’s partnerships with developers of apps and mobile games have given the company a unique familiarity with smartphone-based technologies and the behavior of smartphone users. Now, AppSwarm plans to apply its business model, which has been successful in the application world, to other industries and has announced a series of acquisitions over the past year. In March 2017, the company announced the purchase of a novel ecommerce website called Namefy, which helps entrepreneurs choose the optimal name for their businesses. In May, it followed that acquisition up with two others. First came AuthLinks.com, which offers bloggers and website owners a unique opportunity to tap into the potential of high authority links, and then Into The VR World, a site that offers a variety of virtual reality (VR) and augmented reality (AR) applications.

AppSwarm has also acquired Urban Bamboo Designs, which markets bracelets, décor, phone cases, smoking gear, sunglasses and watches, all made from bamboo. For environmentally-aware consumers, bamboo is an attractive medium of manufacture. Bamboo is one of the fastest growing plants in the world, growing from 1-to-4 inches in a single day, and regrows quickly after being cut and harvested – thus making it top of the list as a renewable resource. Since the plant’s health is improved by cutting, bamboo can be re-harvested every three years or so without any harmful effects on the environment, whereas hardwoods like oak can take up to 40 years to mature before they can be harvested.

Due to its strength, lightweight nature, flexibility and affordability, bamboo is a common construction replacement material. The versatility of bamboo products offers a wide range of products from fabric to skateboards to medicine, and, because bamboo plants produce 30 percent more oxygen, the plant reduces greenhouse gases.

Apart from its promising foray into the ecommerce and app markets, AppSwarm has its eye on the business applications segment. It currently offers a PDF document scanner app, which turns iPhone and iPad devices into portable document scanners. Scans can then be saved as either images or PDFs. The company is also a player in the digital games space, with a menu suiting a variety of tastes that includes Turtles, Huh? – Learn to Fly, which at one time was ranked as the number one iOS family games app in five countries, as well as Avenging Soldiers, Dead Uncleansed, and Soccers.

For more information, visit the company’s website at www.App-Swarm.com

Let us hear your thoughts: AppSwarm, Inc. Message Board

• Hyalolex for Alzheimer’s and other cannabis-based drugs for pain, epilepsy, and more are raising the market valuation growth potential for IGC
• Phytocannabinoids target protein receptors in the brain, peripheral nervous system and other parts of the body, including the lungs, liver, and other organs
• Cannabidiol makes up as much as 40 percent of cannabis-plant extract and has more potential medical uses than THC

Cannabinoid receptors have been known in the medical community since 1988. India Globalization Capital, Inc. (NYSE MKT: IGC) is the first company to develop revolutionary cannabis-based pharmaceuticals targeting Alzheimer’s. Based on this alone, the company’s market valuation growth potential is high, given the possibilities now recognized for these compounds. IGC has a deep pipeline of products, including recently announced therapies such as IGC-501, for arthritic and neuropathic pain; IGC-502 for canine seizures; and IGC-504 for cachexia, a syndrome often associated with debilitating diseases such as multiple sclerosis, Parkinson’s and cancer.

The potential for growth is strong, as cannabis companies such as Anavex Life Sciences Corp. (NASDAQ: AVXL), AC Immune Ltd. (NASDAQ: ACIU) and others have seen market valuations in the hundreds of millions of dollars and even higher.

While there is no cure for Alzhimer’s, therapies, such as the one IGC is pursuing for Alzheimer’s, hold promise in addressing the disease. Phytocannabinoid treatments are also effective because of the protein receptors in the brain and other tissues of the body. There are several different types; one includes the G protein-coupled receptor family, activated by endocannabinoids the body synthesizes when under stress. These receptors play a role in pain modulation, appetite, mood, and even memory.

There are also CB1 receptors, which are thought to be expressed at the synapses in the brain. They have also been found in the peripheral nerves and in muscle, liver, and lung tissue, as well as in fat. Aside from being associated with pain regulation, these cannabinoid receptors have effects on emotion, sensory perception, memory, cognition, and movement. Some autonomous functions are affected as well. Found in the immune system, CB2 receptors have anti-inflammatory properties and other functions, being based in T cells and B cells. They have also been found in macrophages and hematopoietic cells.

Evidence suggests there are more types of cannabinoid receptors. The known types are activated naturally by endocannabinoids but can also be stimulated by compounds found in cannabis plants and by synthetic cannabinoids, which helped researchers identify the receptors in the first place.

Until recently, it was tetrahydrocannabinol that had the attention of mainstream media, known for its psychotropic effects. However, cannabidiol (CBD), which constitutes up to 40 percent of plant extracts, seems to have more medical applications. It’s widely believed to have anti-psychotic, anti-depressive, anxiety-reducing, and anti-convulsive effects. Therefore, CBD has the potential to be useful to the 50 million people around the world with refractory, or drug resistant, epilepsy; the 1.3 million individuals in the United States affected by cachexia every year; the 5.3 million people in the country with Alzheimer’s disease; and the millions who suffer from chronic pain.

For more information, visit the company’s website at www.IGCInc.us

The world’s most popular form of cryptocurrency – bitcoin – has an enigmatic beginning. Its mysterious founder, Satoshi Nakamoto, bears a fictitious name that has kept the curious guessing as to his/her (or their) identity since bitcoin was created in 2009. In the 2016 movie, “Banking on Bitcoin,” no less than four men are identified as the mystic namesake. Three deny the nomenclature, although the last man, Australian computer scientist Craig Steven Wright, claims to be the elusive founder of bitcoin (http://dtn.fm/Jn6ZB).

Nakamoto’s idea – to develop a digital encrypted currency that can be exchanged for any other traditional currency used throughout the world – has both fascinated and confused the public. Virtual money inherently means there’s no physical currency to have and to hold. That idea made a lot of people nervous and many others interested in it.

After all, if you could purchase your favorite brew, spend a night in America’s iconic Sin City (Las Vegas, of course), or hop on a plane simply by paying with digital currency backed up by no one, would you do it? You can do all these things and more (including ordering a $35,000 Tesla 3) with bitcoin (http://dtn.fm/5nlR3).

Bitcoin’s ballistic rise to prominence in the financial world and virtual pocketbooks of average folks deserves some explanation. This monetary revolution found its niche following the September 2008 financial crisis, when the stock market dived, plunging investors into losses that some are still in the process of recovering from today.

Bitcoin is defined by bitcoin.org as “an innovative payment network and a new kind of money.” It is a peer-to-peer payment network with no middleman. Users send and receive bitcoin within the network of those honoring the system.

The unique thing about bitcoin is that it is transparent. Your personal data can’t be shared, just your transactions and the amounts spent. Everything is tracked and followed on a blockchain, and that’s what instills trust and security among those using bitcoin. To enable this process, bitcoin uses software that anonymously logs and validates the activities of bitcoin users around the globe (http://dtn.fm/UE4kz).

There’s no physical money, but there are a finite number of bitcoin that can be created – 21 million, to be exact. A digital wallet holds your bitcoin, and there are usually few or no associated fees. While you are free to spend your bitcoin as you see fit, refunds are not possible, and, if you lose your digital wallet, well, let’s just say you are going to have a very bad, no-good day. James Howell can attest to that. He lost 7,500 bitcoin worth £4 million by throwing his hard drive away (http://dtn.fm/FB4Hg).

Once bitcoin took off as a legitimate digital currency, its rise in value jumped. From the first exchange of a single bitcoin in 2009 to its current value of over $4,000 today, the cryptocurrency continues to rise. For context, on May 22, 2010, two pizzas were purchased with 10,000 bitcoin worth about $25. In December 2013, those same bitcoin were worth about $7 million, and, by May 2017, the value had jumped to $20 million, making that first bitcoin purchase likely the most expensive lunch in history (http://dtn.fm/tEaR7).

In 2013, Overstock.com became the first major U.S. retailer to accept the digital currency. “We think there’s going to be a market in Bitcoin and we want to get in front of it,” Overstock’s CEO at the time, Patrick Byrne, said in an interview with bitcoin blog newsBTC. “It will put [Overstock] at a competitive edge if, and only if, the general population starts thinking and using bitcoin,” he said (http://dtn.fm/mw6Dh). “We’re willing to take the first step and see.”

Other popular online companies like Newegg, Microsoft and Expedia are also accepting bitcoin. In fact, the number of merchants accepting bitcoin has grown to over 82,000, and there are more than 1,350 bitcoin ATMs worldwide in 55 countries. However, there are still some countries where buying or using bitcoin is either illegal or banned; among them are Vietnam, Iceland, Bolivia, Ecuador, Kyrgyzstan and Bangladesh (http://dtn.fm/5uDNS).

This article wouldn’t be complete without asking, “What’s some of the weirdest things you can buy with Bitcoin?” Among the real-life purchases possible with the cybercurrency are a $1,795 motorized unicycle, two adult Canadian woolly mammoth tusks for $175,000 and a $29 bright yellow, cozy handmade bitcoin plush pillow. Who knows… 10 years from now that pillow could be a highly valued collector’s item (http://dtn.fm/4oKZE).

• Nasdaq Hearings Panel grants decision on listing based on shareholder equity and minimum bid issues, conditional on NETE providing evidence of compliance by October 20, 2017
• NETE says impact of its cost cutting program should be realized by the third quarter of 2017
• Zack’s Research Report projects that NETE will generate sales of $74.6 million by FY2018

Net Element, Inc.’s (NASDAQ: NETE) common stock will continue to be traded on the Nasdaq Capital Market after the company met with the exchange’s Nasdaq Hearings Panel. The panel’s decision to grant the company’s request is conditional on NETE providing evidence of compliance with Nasdaq’s regulations by October 20, 2017, as noted by the company in a news release (http://dtn.fm/AN4sa).

NETE is a cloud-based financial company that accepts electronic payments in an omni-channel environment. The payments are processed at point-of-sale and on mobile devices. The firm also offers management tools for clients. A Zack’s Research report projected that NETE would generate $74.6 million in sales by 2018 (http://dtn.fm/6HWor).

NETE received an initial letter from Nasdaq explaining that, because the company was no longer in compliance with its regulations concerning shareholders’ equity and minimum bid price, its stock would be delisted. In a meeting afterward, NETE presented its plan for Nasdaq regulation compliance on both issues.

“We are working diligently to comply with Nasdaq’s listing requirements while improving shareholder value,” Oleg Firer, chief executive officer of NETE, stated in a news release. However, the company said there can be no assurance it will cure its stockholders’ equity or bid price deficiencies.

Nasdaq requires $2.5 million in shareholder equity. The exchange cited NETE’s shareholder equity of only $1,975,435 for the quarter ended June 30. The exchange also has a regulation requiring a $1 minimum bid.

In a July 2017 letter to shareholders, NETE said its institution of a cost cutting program should be realized by the third quarter of 2017.

For more information, visit the company’s website at www.NetElement.com

• Founded in 1999 to offer financial information to Chinese-speaking investors
• Identifies and executes opportunistic strategies in colossal markets
• Positioning to lead in Chinese CBD and cryptocurrency markets

There’s a lot to like about a company that can swiftly identify opportunity and execute on its strategy. ChineseInvestors.com, Inc. (OTCQB: CIIX) is one company that doesn’t waste time. The company was founded in 1999 to offer real-time market commentary, analysis and educational services to Chinese-speaking investors via its dynamic financial website, www.Chinesefn.com. Success followed, and CIIX steadily increased subscribers to currently exceed one hundred thousand. Armed with insights garnered from years of market analysis, CIIX has consistently looked for growth opportunities for expansion.

In 2016, the company recognized the unprecedented growth opportunity in the legal cannabis industry, where the market is projected to continue to grow at a 27 percent CAGR through 2021 (http://dtn.fm/ACwm4). Once the target market was identified, ChineseInvestors.com started laying the groundwork to capitalize on the growing demand for cannabidiol-based (CBD) nutrition and health products, with a natural focus on Chinese-speaking markets. By the end of 2016, the company had begun implementing its plans for a new website and mobile application in order to facilitate online distribution of CBD oils for the booming global medical marijuana industry. While marijuana use in China is illegal, cannabis-based oils, including hemp-based CBDs, are legal, thus opening a potential market of nearly two billion people for CIIX.

Since launch, the company has continued to identify new markets and expansion targets. Recognizing the enormous untapped market for cannabis-based skin care products, CIIX quickly developed and filed with the China Food and Drug Administration to launch a new skin care line over the next couple months. This quick action will put CIIX first to market with immense upside potential.

Now, the company has latched on to another rapid market mover in cryptocurrencies. The underlying blockchain technology of bitcoin and other cryptocurrencies has the potential to transform transactional business by transferring value anywhere around the world without the need of traditional intermediaries such as clearing firms or banks. The ability to transfer value solely through software could become a transformational breakthrough. It’s no coincidence that the Chinese are dominant players in bitcoin mining and volume.

Just two weeks ago, CIIX announced the launch of a cryptocurrency education and trading subscription service (http://dtn.fm/Fi5eJ). The company also announced plans to launch the first Chinese daily video news broadcast from the NYSE covering cryptocurrency and blockchain technology (http://dtn.fm/y2Kp2).

CIIX continues to identify market openings with colossal upside opportunity, but, even more importantly, CIIX moves rapidly to capitalize on these opportunities.

For more information, visit the company’s website at www.ChineseInvestors.com

Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board

• Company is carving out a niche in a burgeoning market
• Canada’s oil extraction market projected to reach $1.5 billion by 2020
• Impending blanket legalization has poised Canada’s marijuana market for explosive growth

The legal marijuana industry is growing by leaps and bounds in North America—particularly in Canada, where medical cannabis has been nationally legal since 2001 and where Canada’s government has now introduced sweeping legislation aimed at making recreational marijuana use legal by July 2018. Canada-based Algae Dynamics Corp. (OTCQB: ADYNF) is among the cannabis stocks preparing to cash in on the influx of business that is sure to follow such an event.

Algae Dynamics is focused on cannabis oil extraction and medicine delivery systems, endeavoring to offer medical cannabis users a means of enjoying the benefits of medical marijuana without smoking. The company is preparing to exploit a niche market with its development of unique health products and pharmaceuticals utilizing hemp, cannabis and algae oils.

If recreational cannabis is successfully legalized on a national scale, Canada’s market for oil extraction is projected to grow to C$1.5 billion by 2020. In Colorado, 45 percent of cannabis consumers who use dried marijuana have said they would eventually switch over to marijuana extracts and oil, and a similar conversion rate is anticipated for Canada’s market. In view of this, Algae Dynamics is extremely well-positioned for success.

Algae Dynamics has engaged two premier universities to perform research into the various uses of cannabis and hemp oil extracts. In combination with other compounds, cannabis and hemp oil extracts could prove effective in the treatment of colorectal, pancreatic, breast and prostate cancers, as well as in the development of novel pharmacotherapies to treat various mental health conditions.

Algae Dynamics is poised for great success in Canada’s favorable cannabis environment. The legal status of medical marijuana has already positioned the company for profitability, and the impending legalization of recreational marijuana is likely to take Algae Dynamics even further.

For more information, visit the company’s website at www.AlgaeDynamics.com

Let us hear your thoughts: Algae Dynamics Corp. Message Board

• SeeThruEquity initiates coverage of PotNetwork Holding, Inc., sees CAGR in hemp-derived CBD market of 53% through 2020
• Diamond CBD sales achieved at BIG Industry Trade Show, Market Week Event and CHAMPS
• SeeThruEquity estimates company will do $8.3 million in revenue in FY2017, a 712% year-over-year jump

PotNetwork Holding, Inc.’s (OTC: POTN) subsidiary, Diamond CBD Sales, achieved greater than $200,000 in sales at the Big Industry Trade Show in New York on August 10-11 (http://dtn.fm/c4AOh). The show is a leading business-to-business trade show for the vape and smoke industry. In total, at three convention and trade shows within the past month, the subsidiary rang up more than $820,000 in revenues, per updates from PotNetwork Holding.

PotNetwork Holding holds First Capital Venture Corp., which owns Diamond CBD, Inc., a major player in the cannabidiol (CBD) industry marketing brands nationally, in all 50 states, as well as internationally, including CBD Gummies, Chill Gummies, CBD Liquid Gold, Blue CBD and many others.

SeeThruEquity has initiated coverage of PotNetwork Holding, setting a target price of $0.25 per share (http://dtn.fm/YX4tU). The report sees the company as a high-risk, high-reward stock in the growing legal cannabis and hemp industry. The target price assumes the market will expand and the company will be successful in its aggressive marketing campaigns. It sees the hemp-derived CBD market as growing at a compound annual growth rate (CAGR) of 53% through 2020.

In addition to the $200,000 at the BIG Industry Trade Show, Diamond CBD also generated sales of more than $320,000 at the Market Week Event, held in Las Vegas. Late in July, the firm also recorded revenues of some $300,000 at the CHAMPS trade show in Las Vegas, PotNetwork Holding said.

Exhibitors at the BIG Industry Trade Show include manufacturers, distributors, store owners and wholesalers in the counter-culture vape and smoke industry. Diamond CBD’s team includes pioneers of the hemp industry, as well as scientists, chemists, and other experts.

For more information, visit the company’s website at www.PotNetworkHolding.com

Let us hear your thoughts: PotNetwork Holding, Inc. Message Board

• Environmentally-controlled growing chambers generate consistent, superior quality
• Proprietary technologies eliminate risk, ensuring patients enjoy peace of mind
• Publicly-traded ABcann entered funding deal for $15 million at $2.25 per share

The Canadian government’s recent announcement that Broken Coast Cannabis Ltd. is recalling several products sold last year after two banned pesticides were found in random samples illustrates the importance of ABcann Global Corp.’s (TSX.V: ABCN) (OTCQB: ABCCF) controlled, pesticide-free approach to growing medical marijuana (http://dtn.fm/8ZOgn).

Several other cannabis-growing Canadian companies also reaped the attention of authorities following mandatory testing. Hydropothecary and Peace Naturals both had products recalled earlier this year following detection of banned pesticides in some products, while Supreme Pharmaceuticals Inc. is still awaiting its license from Health Canada to grow and sell medical cannabis (http://dtn.fm/CS5es).

In contrast, ABcann’s flagship production facility in Napanee, Ontario, continues to meet demand, even as its expansion plans move forward with an expedited construction timeline announced last month (http://dtn.fm/d1JLJ).

“ABcann has moved methodically through each stage of our growth since first obtaining our license in 2014,” founder and director Ken Clement said in an update published on the company’s website. “Providing a high quality, standardized pesticide-free product to our patients remains our number one priority as we initiate our largest expansion plans to date.”

ABcann has approximately $43 million in cash and 100 percent ownership of a 65-acre parcel located not far from its current facility. Phase 1 of the expansion project includes building a 100,000 square foot facility with an annual production capacity of about 1,000 kilograms of cannabis (http://dtn.fm/7cDSD).

A recent $15 million investment in the company by Cannabis Wheaton, part of a $30 million commitment, underscores the company’s belief in ABcann’s tremendous potential for growth (http://dtn.fm/q3PCC).

ABcann’s commitment to growing and providing standardized quality products for the medical marijuana community is a critical component of its future growth plans. The company’s mission, says Clement, is “to deliver consistent, standardized medical cannabis that the public and patients can consistently rely on.”

For more information, visit the company’s website at www.ABcann.ca

Let us hear your thoughts: ABcann Global Corp. Message Board